Literature DB >> 15023861

Membrane-association and the sensitivity of guanylyl cyclase-coupled receptors to nitric oxide.

Victoria Wykes1, John Garthwaite.   

Abstract

Nitric oxide (NO) signal transduction occurs through guanylyl cyclase-coupled receptors, which exist in both cytosolic and membranous locations. It has recently been reported from experiments using heart tissue that the membrane-associated receptor has enhanced sensitivity to NO. Owing to its potential importance, we tested this finding using a method of applying NO in known, constant concentrations. The results showed that the concentration-response curves for receptor activation in cytosolic and membrane preparations of two different tissues (cerebellum and platelets) were indistinguishable. In all cases, half-maximal activation required about 1 nM NO and the curves had Hill coefficients of close to 1. The differential sensitivity reported for the heart is attributed to NO being scavenged by myoglobin in the cytosol, but not in the membrane fraction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023861      PMCID: PMC1574895          DOI: 10.1038/sj.bjp.0705745

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes.

Authors:  M Russwurm; N Wittau; D Koesling
Journal:  J Biol Chem       Date:  2001-09-25       Impact factor: 5.157

3.  A new and simple method for delivering clamped nitric oxide concentrations in the physiological range: application to activation of guanylyl cyclase-coupled nitric oxide receptors.

Authors:  Charmaine Griffiths; Victoria Wykes; Tomas C Bellamy; John Garthwaite
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

4.  Properties of NO-activated guanylyl cyclases expressed in cells.

Authors:  Barry J Gibb; Victoria Wykes; John Garthwaite
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 5.  Regulation of nitric oxide-sensitive guanylyl cyclase.

Authors:  Andreas Friebe; Doris Koesling
Journal:  Circ Res       Date:  2003-07-25       Impact factor: 17.367

Review 6.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

7.  Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide.

Authors:  Ulrike Zabel; Christoph Kleinschnitz; Phil Oh; Pavel Nedvetsky; Albert Smolenski; Helmut Müller; Petra Kronich; Peter Kugler; Ulrich Walter; Jan E Schnitzer; Harald H H W Schmidt
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

8.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

Authors:  W P Arnold; C K Mittal; S Katsuki; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Disruption of myoglobin in mice induces multiple compensatory mechanisms.

Authors:  A Gödecke; U Flögel; K Zanger; Z Ding; J Hirchenhain; U K Decking; J Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

10.  Differential sensitivity of guanylyl cyclase and mitochondrial respiration to nitric oxide measured using clamped concentrations.

Authors:  Tomas C Bellamy; Charmaine Griffiths; John Garthwaite
Journal:  J Biol Chem       Date:  2002-06-21       Impact factor: 5.157

View more
  10 in total

1.  Nitric oxide activation of guanylyl cyclase in cells revisited.

Authors:  Brijesh Roy; John Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

Review 2.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

3.  Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.

Authors:  Saumya Ramanathan; Stacy Mazzalupo; Scott Boitano; William R Montfort
Journal:  Biochemistry       Date:  2011-08-16       Impact factor: 3.162

Review 4.  Role of nitric oxide in cerebellar development and function: focus on granule neurons.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

5.  Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle.

Authors:  Kara F Held; Wolfgang R Dostmann
Journal:  Front Pharmacol       Date:  2012-07-12       Impact factor: 5.810

Review 6.  Concepts of neural nitric oxide-mediated transmission.

Authors:  John Garthwaite
Journal:  Eur J Neurosci       Date:  2008-06       Impact factor: 3.386

7.  cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development.

Authors:  Andreas Friebe; Peter Sandner; Achim Schmidtko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-18       Impact factor: 3.000

8.  Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts.

Authors:  Lukas Menges; Christian Krawutschke; Ernst-Martin Füchtbauer; Annette Füchtbauer; Peter Sandner; Doris Koesling; Michael Russwurm
Journal:  Br J Pharmacol       Date:  2019-12-27       Impact factor: 8.739

9.  Noradrenergic terminal short-term potentiation enables modality-selective integration of sensory input and vigilance state.

Authors:  Shawn R Gray; Liang Ye; Jing Yong Ye; Martin Paukert
Journal:  Sci Adv       Date:  2021-12-17       Impact factor: 14.136

Review 10.  Regulation of soluble guanylate cyclase by matricellular thrombospondins: implications for blood flow.

Authors:  Natasha M Rogers; Franziska Seeger; Elsa D Garcin; David D Roberts; Jeffrey S Isenberg
Journal:  Front Physiol       Date:  2014-04-04       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.